Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Post Marketing Non Interventional Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive LHRH Analogues and to Evaluate the Effect of LHRH Analogues on Lower Urinary Tract Symptoms (ANALUTS Study)

NCT02542501 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02542501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02542501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Post Marketing Non Interventional Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive LHRH Analogues and to Evaluate the Effect of LHRH Analogues on Lower Urinary Tract Symptoms (ANALUTS Study)
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
July 31, 2015
Completion date
July 21, 2018
Enrollment
470 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer